Oncothyreon (ONTY) Misses Q4 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Oncothyreon (ONTY) Misses Q4 EPS by 21c
March 10, 2015 4:01 PM EDT
SEATTLE, March 10, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq: ONTY) today reported financial results for the year and quarter ended December 31, 2014.
Net loss for the year ended December 31, 2014 was $50.0 million, or $0.64 per basic and diluted share, compared with a net loss of $38.8 million, or $0.62 per basic and diluted share, for the comparable period in 2013. The increase in net loss was due to higher research and development expenses, primarily as a result of an increase of $10.0 million in license fees paid to Array. The increase in net loss was also the result of higher general and... More
March 10, 2015 4:01 PM EDT
SEATTLE, March 10, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq: ONTY) today reported financial results for the year and quarter ended December 31, 2014.
Net loss for the year ended December 31, 2014 was $50.0 million, or $0.64 per basic and diluted share, compared with a net loss of $38.8 million, or $0.62 per basic and diluted share, for the comparable period in 2013. The increase in net loss was due to higher research and development expenses, primarily as a result of an increase of $10.0 million in license fees paid to Array. The increase in net loss was also the result of higher general and... More
